An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

October 19, 2023

Primary Completion Date

April 18, 2024

Study Completion Date

May 6, 2024

Conditions
Multiple SclerosisLung CancerBreast Cancer
Interventions
DEVICE

CT-100-D-004-A

Attention Biases App CT-100-D-004-A Digital Neuro-activation and Modulation (DiNaMo) component uses implicit training to redirect and strengthen attention processes. This intervention can help improve cognitive capabilities as well as redirect attentional biases to make participants less sensitive to distressing stimuli.

DEVICE

CT-100-D-004-B

Attention Biases App CT-100-D-004-B Digital Neuro-activation and Modulation (DiNaMo) component uses implicit training to redirect and strengthen attention processes. This intervention can help improve cognitive capabilities as well as redirect attentional biases to make participants less sensitive to distressing stimuli.

Trial Locations (1)

10013

Click Therapeutics, New York

Sponsors
All Listed Sponsors
lead

Click Therapeutics, Inc.

INDUSTRY